Get started
CNS Pharmaceuticals, Inc.CNS Pharmaceuticals, Inc.CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CNSP chart


Full chart

CNSP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.49 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−75.0195 USD
Net income (FY)
‪−18.85 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪56.89 M‬
Beta (1Y)
1.42

Employees


Employees (FY)
5
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.77 M‬ USD

About CNS Pharmaceuticals, Inc.


Sector
Health Technology
CEO
John M. Climaco
Headquarters
Houston
Website
cnspharma.com
Founded
2017
FIGI
BBG00PM24T16
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CNSP news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CNSP is 0.1119 USD — it has decreased by −1.74% in the past 24 hours. Watch CNS Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CNS Pharmaceuticals, Inc. stocks are traded under the ticker CNSP.
CNSP stock has risen by 7.52% compared to the previous week, the month change is a −4.24% fall, over the last year CNS Pharmaceuticals, Inc. has showed a −99.82% decrease.
We've gathered analysts' opinions on CNS Pharmaceuticals, Inc. future price: according to them, CNSP price has a max estimate of 0.50 USD and a min estimate of 0.50 USD. Watch CNSP chart and read a more detailed CNS Pharmaceuticals, Inc. stock forecast: see what analysts think of CNS Pharmaceuticals, Inc. and suggest that you do with its stocks.
CNSP reached its all-time high on Nov 19, 2019 with the price of 8,534.8500 USD, and its all-time low was 0.0955 USD and was reached on Aug 16, 2024. View more price dynamics on CNSP chart.
See other stocks reaching their highest and lowest prices.
CNSP stock is 5.56% volatile and has beta coefficient of 1.42. Track CNS Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is CNS Pharmaceuticals, Inc. there?
Today CNS Pharmaceuticals, Inc. has the market capitalization of ‪6.49 M‬, it has decreased by −2.68% over the last week.
Yes, you can track CNS Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
CNS Pharmaceuticals, Inc. is going to release the next earnings report on Apr 7, 2025. Keep track of upcoming events with our Earnings Calendar.
CNSP earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.10 USD resulting in a −150.00% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about CNS Pharmaceuticals, Inc. earnings.
CNSP net income for the last quarter is ‪−5.61 M‬ USD, while the quarter before that showed ‪−2.53 M‬ USD of net income which accounts for −121.51% change. Track more CNS Pharmaceuticals, Inc. financial stats to get the full picture.
No, CNSP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 5.00 employees. See our rating of the largest employees — is CNS Pharmaceuticals, Inc. on this list?
Like other stocks, CNSP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CNS Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CNS Pharmaceuticals, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CNS Pharmaceuticals, Inc. stock shows the sell signal. See more of CNS Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.